LAUSR

At the end of May 2022, 3 billion COVID-19 vaccine doses have been given in China, which posed an unprecedented challenge to the health care system.1,2 Our hospital is a tertiary grade A hospital in Shenzhen, a city with 17.6 million people. Starting on December 15, 2020, this hospital was the first in Shenzhen authorized for emergency use of the COVID-19 vaccine for high-risk populations, with a daily vaccination rate of around 150. Four months later, this hospital was the designated hospital serving foreign visitors in addition to residents. Due to the waning immunity after vaccination, we realized the perpetual nature of COVID-19 vaccination efforts.3 Subsequently, we developed a 600 m2 vaccination center in August 2021 to accomplish 1200 vaccinations daily. This report describes our tactical strategies to endeavor the challenges by incorporating the core policies in setting up a mass vaccination center. With a 3 × 3 matrix of human factors, spatial layout design, and logistics planning, we addressed the issues of infection control, vaccination safety, and efficiency improvement (Table 1). We believe this framework may serve as a template for future planning and managing mass vaccination centers.